Genetic screening of the G2019S mutation of the LRRK2 gene in southwest European, North African, and sephardic Jewish subjects

Genetic Testing

Volumn 12, Issue 3, 2008, Pages 333-339

  Change, Nathalie ^a   Mercier, Géraldine ^a   Lucotte, Gérard ^a,b  

^a Center of Molecular Neurogenetics   (France)

^b Centre de Neurogenetique Moleculaire   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LEUCINE RICH REPEAT KINASE 2;

ADULT; ARAB; ARTICLE; EUROPE; FEMALE; GENE MUTATION; GENETIC SCREENING; HAPLOTYPE; HETEROZYGOTE DETECTION; HUMAN; INCIDENCE; JEW; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NORTH AFRICA; PARKINSON DISEASE; POPULATION GENETICS;

AFRICAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC SCREENING; GEOGRAPHY; HAPLOTYPES; HETEROZYGOTE; HUMANS; INCIDENCE; JEWS; MALE; MICROSATELLITE REPEATS; MOROCCO; MUTATION; PROTEIN-SERINE-THREONINE KINASES;

EID: 50649119272     PISSN: 10906576     EISSN: None     Source Type: Journal    
DOI: 10.1089/gte.2007.0098     Document Type: Article

References (29)

1. Berg D, Schweitzer KJ, Leitner P, et al. (2005) Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease. Brain 128:3000-3011.
2. Bras JM, Guerreiro RJ, Ribeiro MH, et al. (2005) G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov Disord 20:1653-1655.
3. Di Fonzo A, Rohe CF, Ferreira J, et al. (2005) A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 365:412-415.
4. Funalot B, Nichols WC, Péres-Tur J, et al. (2006) Ancient European LRRK2 mutations in French patients with idiopathic Parkinson's disease. Genet Test 10:290-293.
5. Gaig C, Ezquerra M, Marti MJ, et al. (2006) LRRK2 mutations in Spanish patients with Parkinson's disease: frequency, clinical features and incomplete penetrance. Arch Neurol 63:377-382.
6. Gasser T (2005) Genetics of Parkinson's disease. Curr Opin Neurol 18:363-369.
7. Gautreau C, Rahuel C, Cartron JP, Lucotte G (1983) Comparison of two methods of high-molecular-weight DNA isolation from human leucocytes. Anal Biochem 134:320-324.
8. Gilks WP, Abou-Sleiman PM, Gandhi S, et al. (2005) A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 365:415-416.
9. Goldwurm S, Zini M, Mariani L, et al. (2007) Relevance for genetic counseling in Parkinson's disease. Neurology 68:1141-1143.
10. Ishihara L, Gibson RA, Warren L, et al. (2006) Screening for LRRK2 G2019S and clinical comparison of Tunisian and North American Caucasian Parkinson's disease families. Mov Disord 22:55-61.
11. Ishihara L, Warren L, Gibson R, et al. (2007) Clinical features of Parkinson's disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations. Arch Neurol 63:1250-1254.
12. Kachergus J, Mata IF, Huliham M, et al. (2005) Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence for a common founder across European populations. Am J Hum Genet 76:672-680.
13. Lesage S, Dürr A, Tazir M, et al. (2006) LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 26:422-423.
14. Lesage S, Ibanez P, Lohmann E, et al. (2005a) G2019S LRRK2 mutation in French and North African families with Parkinson's disease. Ann Neurol 58:784-787.
15. Lesage S, Leutenegger AL, Ibanez P, et al. (2005b) LRRK2 haplotype analysis in European and North African families with Parkinson's disease: a common fund for the G2019S mutation dating from the 13th century. Am J Hum Genet 77:330-332.
16. Lucotte G, Aouizérate A, Berriche S (2000) Y-chromosome DNA haplotypes in North African populations. Hum Biol 72:473-480.
17. Lucotte G, David F, Berriche S (1996) Haplotype VIII of the Y chromosome is the ancestral haplotype in Jews. Hum Biol 68:467-471.
18. Lucotte G, Gérard N, Mercier G (2001) North-African genes in Iberia studied by chromosome DNA haplotype V. Hum Immunol 62:885-888.
19. Lucotte G, Hazout S (1996) Y-chromosome DNA haplotypes in Basques. J Mol Evol 42:472-475.
20. Mata I, Kachergus JM, Taylor JP, et al. (2005) LRRK2 pathogenic substitutions in Parkinson's disease. Neurogenetics 6:171-177.
21. Mata IF, Ross OA, Kachergus J, et al. (2006) LRRK2 mutations are a common cause of Parkinson's disease in Spain. Eur J Neurol 13:391-394.
22. McInerney-Leo A (2005) Genetic testing in Parkinson's disease. Mov Disord 20:908-909.
23. Mercier G, Bathelier C, Lucotte G (2005) Connexin 26 mutation 35delG: prevalence of carriers in various regions in France. Int J Pediatr Otorhinolaryngol 69:1187-1190.
24. Nichols WC, Pankratz N, Hernandez D, et al. (2005) Genetic screening for a single common LRRK2 mutation in familial Parkinson's disease. Lancet 365:410-412.
25. Ozelius LJ, Senthil G, Saunders-Pullman R, et al. (2006) LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 26:424-425.
26. Paisán-Ruiz C, Jain S, Evans EW, et al. (2004) Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 44:595-600.
27. Watterson GA, Guess HA (1977) Is the most frequent allele the oldest? Theor Popul Biol 11:141-160.
28. Zabetian CP, Hutter CM, Yearout D, et al. (2006) LRRK2 G2019S in families with Parkinson's disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago. Am J Hum Genet 789:752-758.
29. Zimprich A, Biskup S, Leitner P, et al. (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601-607.